{
  "context": {
    "rules": [
      "Rule1: If the platform classifies a variant, then data is available for the platform.",
      "Rule2: Provided that the platform uses machine learning, the platform has an accurate detection.",
      "Rule3: The platform uses machine learning or the platform uses a statistical model.",
      "Rule4: Under the condition that the platform uses a statistical model, the platform validates findings.",
      "Rule5: If the platform validates findings, then the platform does not have a false positive detection.",
      "Rule6: The platform receives government funding or the platform receives private funding.",
      "Rule7: Provided that the platform receives private funding, if the platform monitors an outbreak, then the platform provides global health benefit.",
      "Rule8: If research is approved for the platform, then under the condition that the platform receives government funding, whenever the platform monitors an outbreak, the platform provides global health benefit.",
      "Rule9: Provided that the platform detects the COVID-19 virus, the platform detects the Ebola virus.",
      "Rule10: If the platform passes peer review, then research is approved for the platform.",
      "Rule11: Under the condition that the platform passes technical validation, research is approved for the platform.",
      "Rule12: Whenever the platform publishes results, the platform publishes in JAMA.",
      "Rule13: The platform publishes results or the platform issues an internal report only.",
      "Rule14: If the platform issues an internal report only, then the platform passes technical validation.",
      "Rule15: Under the condition that the platform publishes in an international journal, the platform passes peer review.",
      "Rule16: If the lead researcher approves the platform, then provided that the platform publishes results, the platform publishes in an international journal.",
      "Rule17: Either the lead researcher approves the platform or the team approves the platform.",
      "Rule18: If the team approves the platform, then under the condition that the platform publishes results, the platform publishes in an international journal.",
      "Rule19: Genomic analysis is complete for the platform or if it is not the case that if the platform identifies a new variant then data is available for the platform, then the platform has a variant classification error.",
      "Rule20: If the platform uses NGS technology, then sequencing quality is high for the platform.",
      "Rule21: The platform uses NGS technology or the platform uses PCR technology.",
      "Rule22: If method validation is required for the platform, then provided that it is not the case that if the platform uses PCR technology then it is not the case that genomic analysis is complete for the platform, the sequencing method is invalid for the platform.",
      "Rule23: If the platform uses cloud computing, then the platform performs real-time processing.",
      "Rule24: Provided that the platform uses local computing, if the platform analyzes genetic sequences then data is available for the platform.",
      "Rule25: Computational resources are allocated for the platform or resource allocation is pending for the platform.",
      "Rule26: Under the condition that resource allocation is pending for the platform, the platform uses cloud computing or the platform uses local computing.",
      "Rule27: The system is online for the platform or if the platform detects the Ebola virus then the platform detects the influenza virus.",
      "Rule28: If deployment is successful for the platform, then system performance is high for the platform or processing is optimized for the platform or if computational resources are allocated for the platform then the platform uses cloud computing or the platform uses local computing.",
      "Rule29: Provided that contact tracing is enabled for the platform, an infection cluster is identified by the platform.",
      "Rule30: A privacy violation occurs on the platform or if an infection cluster is identified by the platform then data is available for the platform.",
      "Rule31: If the platform is compliance certified, then data is encrypted on the platform.",
      "Rule32: If the platform passes a security audit, then provided that data is encrypted on the platform, it is not the case that a privacy violation occurs on the platform.",
      "Rule33: The platform passes a security audit or security protocols are implemented on the platform.",
      "Rule34: If security protocols are implemented on the platform, then under the condition that data is encrypted on the platform, a privacy violation does not occur on the platform.",
      "Rule35: If data is available for the platform, then the platform provides global health benefit.",
      "Rule36: Under the condition that sensitivity is high for the platform, the platform has a false negative detection.",
      "Rule37: If sensitivity calibration is complete for the platform, then provided that the detection threshold is low for the platform, sensitivity is high for the platform.",
      "Rule38: Provided that default sensitivity is used by the platform, if the detection threshold is low for the platform then sensitivity is high for the platform.",
      "Rule39: If calibration is approved for the platform, then sensitivity calibration is complete for the platform.",
      "Rule40: Under the condition that manual calibration is required for the platform, default sensitivity is used by the platform.",
      "Rule41: If model validation is complete for the platform, then provided that the platform uses a statistical model, it is not the case that the platform has a false positive detection.",
      "Rule42: If a user reports symptoms to the platform, then the platform processes data from the user.",
      "Rule43: Cross-validation is performed on the platform or holdout validation is performed on the platform.",
      "Rule44: If holdout validation is performed on the platform, then a validation dataset is available for the platform or if the model is overfitting on the platform then it is not the case that the model is underfitting on the platform.",
      "Rule45: Under the condition that validation results are consistent for the platform, a validation dataset is available for the platform or if the model is overfitting on the platform then it is not the case that the model is underfitting on the platform.",
      "Rule46: If the performance benchmark is met by the platform, then model performance is adequate for the platform.",
      "Rule47: The performance benchmark is met by the platform or performance evaluation is pending for the platform.",
      "Rule48: Provided that performance evaluation is pending for the platform, if cross-validation is performed on the platform then validation results are consistent for the platform.",
      "Rule49: If outbreak tracking is active for the platform, then the platform provides global health benefit.",
      "Rule50: Provided that the tracking algorithm is optimized for the platform, if the platform monitors an outbreak then outbreak tracking is active for the platform.",
      "Rule51: The tracking algorithm is optimized for the platform or baseline tracking is used by the platform.",
      "Rule52: If the platform processes data from the user, then contact tracing is enabled for the platform.",
      "Rule53: Under the condition that the platform processes data from the user, the platform analyzes genetic sequences.",
      "Rule54: If the tracking system is reliable for the platform, then provided that baseline tracking is used by the platform, if the platform monitors an outbreak then outbreak tracking is active for the platform.",
      "Rule55: Tracking data is complete for the platform or the tracking system is reliable for the platform.",
      "Rule56: Publication impact is high for the platform or if the platform publishes in JAMA then the platform passes peer review.",
      "Rule57: Provided that research is influential for the platform, policy changes are made due to the platform.",
      "Rule58: Research is influential for the platform or citation count is high for the platform or it is not the case that publication impact is high for the platform.",
      "Rule59: If evidence is insufficient for the platform, then it is not the case that policy changes are made due to the platform.",
      "Rule60: Evidence is insufficient for the platform or further study is needed for the platform.",
      "Rule61: Under the condition that further study is needed for the platform, it is not the case that policy changes are made due to the platform.",
      "Rule62: If public health alerts are issued by the platform, then the platform provides global health benefit.",
      "Rule63: If the platform analyzes genetic sequences, then the platform identifies a new variant.",
      "Rule64: Under the condition that the platform is under system maintenance, it is not the case that monitoring is suspended for the platform.",
      "Rule65: The platform is under system maintenance or the platform has technical issues.",
      "Rule66: Ethical approval is granted for the platform or if ethics review is complete for the platform then it is not the case that there are ethical concerns for the platform.",
      "Rule67: An ethical violation occurs on the platform or it is not the case that ethical approval is granted for the platform.",
      "Rule68: If compliance is verified for the platform, then it is not the case that an ethical violation occurs on the platform.",
      "Rule69: Provided that the platform identifies a new variant, the platform classifies a variant.",
      "Rule70: Under the condition that it is not the case that either the platform has an accurate detection or it is not the case that the platform has a false positive detection, the detection threshold is low for the platform.",
      "Rule71: If it is not the case that if the platform monitors an outbreak then public health alerts are issued by the platform, then monitoring is suspended for the platform.",
      "Rule72: If it is not the case that if the platform uses PCR technology then it is not the case that genomic analysis is complete for the platform, then it is not the case that the sequencing method is invalid for the platform.",
      "Rule73: Under the condition that it is not the case that either calibration is approved for the platform or manual calibration is required for the platform, a calibration error occurs on the platform.",
      "Rule74: If it is not the case that either calibration is approved for the platform or manual calibration is required for the platform, then it is not the case that a calibration error occurs on the platform.",
      "Rule75: Provided that it is not the case that if the platform has technical issues then it is not the case that monitoring is suspended for the platform, there is a maintenance schedule conflict for the platform.",
      "Rule76: If it is not the case that if the platform has technical issues then it is not the case that monitoring is suspended for the platform, then it is not the case that there is a maintenance schedule conflict for the platform.",
      "Rule77: If it is not the case that if the platform identifies a new variant then data is available for the platform, then it is not the case that the platform has a variant classification error.",
      "Rule78: Provided that it is not the case that if it is not the case that research is approved for the platform then research is rejected for the platform, there are ethical concerns for the platform.",
      "Rule79: Under the condition that it is not the case that research is approved for the platform, it is not the case that research is rejected for the platform.",
      "Rule80: If it is not the case that model validation is complete for the platform, then the model is underfitting on the platform.",
      "Rule81: Provided that it is not the case that model validation is complete for the platform, the model is overfitting on the platform.",
      "Rule82: Provided that it is not the case that the platform provides global health benefit, the platform has a false positive detection.",
      "Rule83: If it is not the case that the platform provides global health benefit, then the platform detects the COVID-19 virus.",
      "Rule84: Under the condition that it is not the case that the platform provides global health benefit, it is not the case that the platform detects the influenza virus."
    ],
    "facts": [
      "Fact1: The platform monitors an outbreak.",
      "Fact2: Method validation is required for the platform.",
      "Fact3: Deployment is successful for the platform.",
      "Fact4: The platform is compliance certified.",
      "Fact5: A user reports symptoms to the platform.",
      "Fact6: Ethics review is complete for the platform.",
      "Fact7: Compliance is verified for the platform.",
      "Fact8: It is not the case that the platform has an accurate detection.",
      "Fact9: It is not the case that sequencing quality is high for the platform.",
      "Fact10: It is not the case that the platform performs real-time processing.",
      "Fact11: It is not the case that processing is optimized for the platform.",
      "Fact12: It is not the case that the system is online for the platform.",
      "Fact13: It is not the case that system performance is high for the platform.",
      "Fact14: It is not the case that the platform has a false negative detection.",
      "Fact15: It is not the case that a validation dataset is available for the platform.",
      "Fact16: It is not the case that model performance is adequate for the platform.",
      "Fact17: It is not the case that tracking data is complete for the platform.",
      "Fact18: It is not the case that citation count is high for the platform."
    ]
  },
  "question": "The platform provides global health benefit."
}